| Date Filed | Type | Description |
| 08/24/2023 |
4
| Seizinger Bernd R. (Director) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 500 shares
@ $0
Granted 2,000 options to buy
@ $3.65, valued at
$7.3k
|
|
| 06/08/2023 |
4
| Seizinger Bernd R. (Director) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Bought 4,068 shares
@ $3.6294, valued at
$14.8k
Bought 6,029 shares
@ $3.6809, valued at
$22.2k
|
|
| 01/23/2023 |
4
| Seizinger Bernd R. (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.66, valued at
$66k
|
|
| 09/16/2022 |
4
| Seizinger Bernd R. (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 50,000 options to buy
@ $0.74, valued at
$37k
|
|
| 09/16/2022 |
3
| Seizinger Bernd R. (Director) has filed a Form 3 on Aptose Biosciences Inc. |
| 08/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |